We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In response to price controls imposed by India’s National Pharmaceutical Pricing Authority, Abbott pulled its Xience Alpine drug-eluting stent from the Indian market. Read More
The tariffs would hit a large number of devices such as catheters, imaging devices, anesthetic instruments and defibrillators, as well as hearing aids, pacemakers and artificial body parts. Read More
U.S. medical device manufacturers could be impacted by the Trump administration’s proposed 25 percent tariffs on thousands of Chinese goods,… Read More
Upon the regulatory approval of the device, Surmodics will be responsible for the manufacture and supply of clinical and commercial quantities of the product. Read More
Industry groups such as AdvaMed argued the caps would negatively impact manufacturers’ ability to pay for future R&D investments and job creation. Read More
Boston Scientific is facing regulatory hurdles with its proposed manufacturing process and design changes to bring its transcatheter aortic valve back to the U.S. and EU markets. Read More